<drug type="small molecule" created="2015-11-30" updated="2016-08-17">
  <drugbank-id primary="true">DB09563</drugbank-id>
  <name>Choline C-11</name>
  <description/>
  <cas-number/>
  <unii>M4AS4XGD4Q</unii>
  <groups>
    <group>approved</group>
  </groups>
  <general-references>
    <articles/>
    <textbooks/>
    <links/>
  </general-references>
  <synthesis-reference/>
  <indication/>
  <pharmacodynamics/>
  <mechanism-of-action/>
  <toxicity/>
  <metabolism/>
  <absorption/>
  <half-life/>
  <protein-binding/>
  <route-of-elimination/>
  <volume-of-distribution/>
  <clearance/>
  <salts/>
  <synonyms/>
  <products>
    <product>
      <name>Choline C 11</name>
      <labeller>Washington University School Of Medicine</labeller>
      <ndc-id/>
      <ndc-product-code>75913-311</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2016-06-24</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength>33.1 mCi/mL</strength>
      <route>Intravenous</route>
      <fda-application-number>ANDA208413</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Choline C 11</name>
      <labeller>University Of Texas Md Anderson Cancer Center</labeller>
      <ndc-id/>
      <ndc-product-code>60215-110</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2015-10-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength>33.1 mCi/mL</strength>
      <route>Intravenous</route>
      <fda-application-number>ANDA205690</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Choline C 11</name>
      <labeller>Mayo Clinic</labeller>
      <ndc-id/>
      <ndc-product-code>52670-556</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2012-09-12</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength>33.1 mCi/mL</strength>
      <route>Intravenous</route>
      <fda-application-number>NDA203155</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Choline C 11</name>
      <labeller>Global Isotopes, Llc D/B/A Zevacor Molecular</labeller>
      <ndc-id/>
      <ndc-product-code>69126-004</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2015-01-15</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength>4 mCi/mL</strength>
      <route>Intravenous</route>
      <fda-application-number>ANDA206319</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Choline C 11</name>
      <labeller>University Of Texas Md Anderson Cancer Center</labeller>
      <ndc-id/>
      <ndc-product-code>60215-111</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2015-10-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength>100 mCi/mL</strength>
      <route>Intravenous</route>
      <fda-application-number>ANDA205690</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Choline C 11</name>
      <labeller>Precision Nuclear Llc</labeller>
      <ndc-id/>
      <ndc-product-code>52768-300</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2013-06-07</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength>33.1 mCi/mL</strength>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
  </products>
  <international-brands/>
  <mixtures>
    <mixture>
      <name>Choline C 11</name>
      <ingredients>Choline C-11</ingredients>
    </mixture>
    <mixture>
      <name>Choline C 11</name>
      <ingredients>Choline C-11</ingredients>
    </mixture>
    <mixture>
      <name>Choline C 11</name>
      <ingredients>Choline C-11</ingredients>
    </mixture>
    <mixture>
      <name>Choline C 11</name>
      <ingredients>Choline C-11</ingredients>
    </mixture>
    <mixture>
      <name>Choline C 11</name>
      <ingredients>Choline C-11</ingredients>
    </mixture>
    <mixture>
      <name>Choline C 11</name>
      <ingredients>Choline C-11</ingredients>
    </mixture>
  </mixtures>
  <packagers/>
  <manufacturers/>
  <prices/>
  <categories/>
  <affected-organisms/>
  <dosages>
    <dosage>
      <form>Injection</form>
      <route>Intravenous</route>
      <strength>100 mCi/mL</strength>
    </dosage>
    <dosage>
      <form>Injection</form>
      <route>Intravenous</route>
      <strength>33.1 mCi/mL</strength>
    </dosage>
    <dosage>
      <form>Injection</form>
      <route>Intravenous</route>
      <strength>4 mCi/mL</strength>
    </dosage>
  </dosages>
  <atc-codes/>
  <ahfs-codes/>
  <pdb-entries/>
  <patents/>
  <food-interactions/>
  <drug-interactions/>
  <calculated-properties/>
  <experimental-properties/>
  <external-identifiers/>
  <external-links/>
  <pathways/>
  <reactions/>
  <snp-effects/>
  <snp-adverse-drug-reactions/>
  <targets/>
  <enzymes/>
  <carriers/>
  <transporters/>
</drug>
